by Erik Valent | Feb 22, 2019 | Uncategorized
The MMpredict consortium has reached a new milestone in this project by completing the recruitment of the patient samples required in this project. With more than 800 myeloma samples recruited, the project team meets its aimed target population. The current efforts...
by Erik Valent | Nov 23, 2018 | Uncategorized
During the 23th EHA congress in Stockholm, Sweden, we have had the opportunity to host our fourth HORIZON 2020 project team meeting. We had an interactive session in which we discussed the project progress and short term future goals. The meeting was finalized by...
by Erik Valent | Nov 12, 2018 | Uncategorized
This month we celebrate the two-year anniversary of our Multiple Myeloma Horizon 2020 research project. Within this period we have made considerable progress towards our central goal of developing a personalized medicine tool that is capable of predicting the most...
by Erik Valent | May 1, 2018 | Uncategorized
The Multiple Myeloma horizon 2020 (MMh2020) initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx B.V., the Department of Haematology of the Erasmus University Medical Centre Rotterdam (Erasmus MC), the Department of...
by Erik Valent | Mar 28, 2018 | Uncategorized
Myeloma Patients Europe (MPE) is running a survey for European myeloma patients to understand their quality of life and how this is impacted by treatment side-effects. To gain knowledge about the current Multiple Myeloma (MM) disease situation in Europe, we ask MM...
